CDKN2B and breast carcinoma: It has been shown that estradiol-induced PIM-1 overexpression in breast cancer leads to the phosphorylation of key proteins, which in turn suppresses the expression of cell cycle inhibitors (CDKN1A and CDKN2B) [50].